M/14/004 – Crimson / OCD
The proposed acquisition of sole control of the Ortho Clinical Diagnostics business by Crimson Bermuda Co. Limited has been cleared by the Competition Authority.
|Notification date||Decision date|
|Tuesday February 4, 2014||Thursday, February 27, 2014|
|Parties Involved||Business activities|
|Crimson Bermuda Co. Ltd||
Crimson is a company controlled by funds managed by affiliates of The Carlyle Group. Carlyle is a global alternative asset manager.
|Ortho Clinical Diagnostics||
OCD is a provider of IVD systems.
|Economic sector||Media merger|
|The in-vitro diagnostic (IVD) sector.||No|
|Submissions from third parties due by:|
|Phase 1||Phase 2|
|Monday, February 17, 2014|
|Current status: Completed|
|Cleared (Phase 1)|
|Authorised Officer Assigned||Contact Details|
Tel: 01-804 5482, e-mail: 01-804 5482
Media enquiries: MKC Communications: 01 7038600